The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcome of patients (pts) with relapsed, advanced upper gastrointestinal (GI) carcinoma treated in a specialist oncology phase I unit.
Khurum Hayat Khan
No relevant relationships to disclose
Joo Ern Ang
No relevant relationships to disclose
Naureen Starling
No relevant relationships to disclose
Krunal Jitendrakumar Shah
No relevant relationships to disclose
L Rhoda Molife
No relevant relationships to disclose
Udai Banerji
No relevant relationships to disclose
Johann Sebastian De Bono
No relevant relationships to disclose
David Cunningham
No relevant relationships to disclose
Stanley B. Kaye
No relevant relationships to disclose